Literature DB >> 22676958

Abnormal sympathetic hyper-reactivity in patients with myasthenia gravis: a prospective study.

Garima Shukla1, Salil Gupta, Vinay Goyal, Sumit Singh, Achal Srivastava, Madhuri Behari.   

Abstract

INTRODUCTION: Patients with myasthenia gravis, especially those in crises, are not infrequently observed to demonstrate wide fluctuation in heart rate and blood pressure.
OBJECTIVE: This study was conducted to assess autonomic function in patients with myasthenia gravis.
METHODS: Patients with myasthenia gravis diagnosed on the basis of typical clinical details, edrophonium or neostigmine test, decremental response on repetitive nerve stimulation testing and anti acetyl choline receptor antibody testing, were compared with age and gender matched controls. Apart from detailed clinical evaluation, all subjects underwent tests of autonomic function, viz. heart rate and blood pressure response on orthostatic tests and isometric handgrip test, Valsalva maneuver, R-R interval variation (RRIV) and the sympathetic skin response (SSR). Results were compared with those in the control group using repeated measures ANOVA and the paired t-test.
RESULTS: Sixty-four patients (27 males, 37 females) with a mean age of 40.5 ± 17 years) with myasthenia gravis of an average 3 ± 4 years duration, and 241 normal controls were enrolled. On the orthostatic tests, patients showed rise in heart rate, systolic and diastolic blood pressure, as did controls, however, the rate and the duration of rise was significantly higher than in the controls (p < 0.01). Similar difference between patients and controls, in rate of rise of these parameters was observed on the isometric hand grip test. No significant difference was observed between the two groups on tests of parasympathetic function (Valsalva ratio, RRIV). These effects could also partially be due to pyridostigmine, which all patients were receiving.
CONCLUSION: This study suggests sympathetic hyper-reactivity in patients with myasthenia gravis, which could be responsible for serious hemodynamic instability in patients in crisis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22676958     DOI: 10.1016/j.clineuro.2012.05.013

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  10 in total

1.  The presence of dysautonomia in different subgroups of myasthenia gravis patients.

Authors:  Ana Nikolić; Stojan Perić; Tanja Nišić; Srdjan Popović; Miroljub Ilić; Vidosava Rakočević Stojanović; Dragana Lavrnić
Journal:  J Neurol       Date:  2014-08-14       Impact factor: 4.849

2.  Decreased salivary α-amylase activity responding to citric acid stimulation in Myasthenia gravis with malnutrition.

Authors:  Ye Huang; Wen-Kai Wang; Xiao-Mei Zheng; Long Yang; Li-Hui Wang; Xiang-Hong Qiu; Long-Hui Chen; Ru-Liu Li; Chuan-Quan Lin
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

Review 3.  Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis.

Authors:  Olivia Tong; Leslie Delfiner; Steven Herskovitz
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

4.  Does cardiovascular autonomic dysfunction contribute to fatigue in myasthenia gravis?

Authors:  A Elsais; E Kerty; K Russell; K Toska
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

5.  The Spectrum of Autonomic Dysfunction in Myasthenic Crisis.

Authors:  Rohit Ninan Benjamin; Sanjith Aaron; Ajith Sivadasan; Suresh Devasahayam; Amalan Sebastin; Mathew Alexander
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

6.  Association of Cardiac Autonomic Responses with Clinical Outcomes of Myasthenia Gravis: Short-Term Analysis of the Heart-Rate and Blood Pressure Variability.

Authors:  Monika Zawadka-Kunikowska; Łukasz Rzepiński; Małgorzata Tafil-Klawe; Jacek J Klawe; Paweł Zalewski; Joanna Słomko
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

7.  Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis-A Pilot Study.

Authors:  Łukasz Rzepiński; Monika Zawadka-Kunikowska; Julia L Newton; Paweł Zalewski
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

8.  Fatigue in myasthenia gravis: is it more than muscular weakness?

Authors:  Ahmed Elsais; Vegard B Wyller; Jon Håvard Loge; Emilia Kerty
Journal:  BMC Neurol       Date:  2013-10-03       Impact factor: 2.474

9.  An Overview of Cardiac Management in Neuromuscular Disease.

Authors:  Renee M Hickey; John D Cullen; George M Sachs
Journal:  Open Cardiovasc Med J       Date:  2016-05-27

10.  Myasthenia Gravis and Associated Diseases.

Authors:  Nikolina Tanovska; Gabriela Novotni; Slobodanka Sazdova-Burneska; Igor Kuzmanovski; Bojan Boshkovski; Goran Kondov; Marija Jovanovski-Srceva; Anita Kokareva; Rozalinda Isjanovska
Journal:  Open Access Maced J Med Sci       Date:  2018-03-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.